Diagnosis

Hypoaldosteronism

Decreased aldosterone production or aldosterone resistance resulting in reduced mineralocorticoid action.

Etiology

Cause [zwp][dad]

  1. Defective synthesis: Hyperreninemic hypoaldosteronism (rare)

    • Immaturity of aldosterone synthetic enzymes in infants

    • Primary adrenal insufficiency (enzyme defect: aldosterone synthase deficiency)

    • Critically ill patients (peritonitis, liver failure, septic shock, pneumonia, cholangitis): diminish aldosterone synthesis by diverting substrate to the production of cortisol

    • Delayed recovery of the suppressed gland after contralateral adrenalectomy

    • Drug-induced diminished synthesis

    • Discontinuation of drugs with mineralocorticoid activity after prolonged use

  2. Defective release: Hyporeninemic hypoaldosteronism (most common)

    1. Congenital (rare: 1 per 80,000)

    2. Acquired (more frequent due to diabetes and RAAS-medications)

      • Diabetes

      • Various nephropathies

      • Autonomic neuropathy

      • Sickle cell disease

      • HIV disease

  3. Medications: NSAIDs, COX-2 inhibitors, ACEI/ARBs, Heparin, β-blockers, Trimethoprim, MRBs, calcineurin inhibitors, potassium-sparing diuretics (spironolactone), pentamidine, ketoconazole, dopamine

  4. Aldosterone resistance:

    • Genetic

      • Autosomal dominant pseudohypoaldosteronism

      • Autosomal recessive pseudohypoaldosteronism

    • Acquired

      • Urinary tract infection and obstructive uropathy

      • Medications

      • Downregulation of mineralocorticoid receptor in renal tubules (solid organ transplant)

Pathophysiology

  1. Renin --> Angiotensin --> Aldosterone (RAA axis) regulates:

    • Sodium (Na)

    • Potassium (K)

    • Extravellular compartment fluid volume

    • Blood pressure

  2. Hypoaldosteronism: Defective synthesis/release of renin, angiotensin, aldosterone

Complications [zwp]

Epidemiology

Incidence per 100.000 [b9n][msy]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Arrhythmia, Hyperpigmentation, Hypotension, Muscle weakness

Clinical findings

Decreased Aldosterone, Hyperkalemia, Hyponatremia, Hypovolemia, Metabolic acidosis

Anamneses

None listed.

Approach

Treatment

  1. Acute salt-wasting crisis: [zwp]

    • Volume and salt repletion with NaCl

    • Intravenous hydrocortisone in stress doses

  2. Maintenance:

    • Mineralocorticoid replacement therapy: 9α-fluorocortisone 0.05-0.1 mg/day

    • Increased water and salt intake

Differential diagnoses

Adrenal insufficiency, Gordon syndrome, Liddle syndrome


References

[1] Rajkumar V, Waseem M. Hypoaldosteronism. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK555992/

[2] https://www.uptodate.com/contents/etiology-diagnosis-and-treatment-of-hypoaldosteronism-type-4-rta

[3] Sousa AG, Cabral JV, El-Feghaly WB, de Sousa LS, Nunes AB. Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management. World J Diabetes. 2016 Mar 10;7(5):101-11.

[4] Ruiz-Sánchez JG, Calle-Pascual AL, Rubio-Herrera MÁ, De Miguel Novoa MP, Gómez-Hoyos E, Runkle I. Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practice. Front Endocrinol (Lausanne). 2022 Oct 11;13:990148.

[5] Wilczynski C, Shah L, Emanuele MA, Emanuele N, Mazhari A. SELECTIVE HYPOALDOSTERONISM: A REVIEW. Endocr Pract. 2015 Aug;21(8):957-65.

Scroll to top